6 Statistics From Study of Average Implant Costs for Orthopedic and Cardiac Procedures in Hospitals

While large reimbursements from orthopedics, spine and cardiac cases may, on their faces, appeal to hospitals, the reality is that implant and device costs associated with the procedures are generally eating up at least one-third of the reimbursement, according to a study presented at the recent IHA CHA Medical Device Conference. Further, the study found, implant pricing varied widely by vendor and across the 11 hospitals examined, and often exceeded the national benchmark figures.

Advertisement

Here are six interesting statistics from the study, carried out by James C. Robinson, PhD, a professor of health economics at the University of California Berkeley.

1. Average total knee replacement (DRG 544) implant cost per case ranged from $3,321 to $8,987. (The national benchmark is about $4,700.)

2. Total knee implant cost as a percentage of average reimbursement ranged from 25 percent to 51 percent.

3. Average lumbar fusion (DRG 498) implant cost per case ranged from $6,959 to $14,689. (The national benchmark is about $7,600.)

4. Lumbar fusion implant cost as a percentage of average reimbursement ranged from 15 percent to 52 percent.

5. Average cardiac defibrillator (DRG 515) cost per case ranged from $19,229 to $29,496. (The national benchmark is about $24,500.)

6. Cardiac defibrillator implant cost as a percentage of average reimbursement ranged from 57 percent to 94 percent.

Download the PDF of the presentation slides for more information, including average reimbursement per case by payor and the contribution margin per case by payor for each hospital.

At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.

Advertisement

Next Up in Uncategorized

  • As the ASC industry continues to grow alongside new waves of surgical innovation, patient preferences and shifts to value-based care,…

  • A Pleasant View, Utah-based physician has been indicted on charges of obtaining unapproved drugs from China and selling them to…

  • From payer obstacles to operational pressures, five ASC leaders discuss the biggest frictions they’re facing. Note: Responses were lightly edited.…

Advertisement

Comments are closed.